531569 — Sanjivani Paranteral Share Price
0.000.00%
Last trade - 00:00- IN₹2.83bn
- IN₹2.85bn
- IN₹544.11m
- 24
- 13
- 57
- 18
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.95 | ||
| Price to Tang. Book | 8.95 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.41 | ||
| EV to EBITDA | 29.06 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 24.24% | ||
| Return on Equity | 44.66% | ||
| Operating Margin | 14.24% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 163.56 | 251 | 306.13 | 354.92 | 544.11 | n/a | n/a | 16.74% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +190.24 | -6.91 | +16.93 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. The Company’s products include oral solids, small volume parenteral and sterile powder formula. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, multivitamin, nutrition, diuretic, anti-hypertensive, and others. Its anti-biotic includes Netilmicin Sulfate, Amikacin Sulfate, and Gentamycin Sulfate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic include Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamins include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, and Diazepam. Its diuretic includes Furosemide.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 5th, 1994
- Public Since
- January 22nd, 1996
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 11,881,694
- Address
- 205, P.N. Kothari Industrial Estate, MUMBAI, 400078
- Web
- https://www.sanjivani.co.in/
- Phone
- +91 2220812600
- Auditors
- M/s R B GOHIL & CO
Upcoming Events for 531569
Q1 2026 Sanjivani Paranteral Ltd Earnings Release
Q2 2026 Sanjivani Paranteral Ltd Earnings Release
Similar to 531569
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Sanjivani Paranteral share price?
As of Today at 23:03 UTC, shares in Sanjivani Paranteral are trading at IN₹240.40. This share price information is delayed by 15 minutes.
How has the Sanjivani Paranteral share price performed this year?
Shares in Sanjivani Paranteral last closed at IN₹240.40 and the price had moved by +29.39% over the past 365 days. In terms of relative price strength the Sanjivani Paranteral share price has outperformed the S&P BSE 100 Index by +21.88% over the past year.
What are the analyst and broker recommendations for Sanjivani Paranteral?
There is no consensus recommendation for this security.
Find out moreWhat is the Sanjivani Paranteral dividend yield?
Sanjivani Paranteral does not currently pay a dividend.
Does Sanjivani Paranteral pay a dividend?
Sanjivani Paranteral does not currently pay a dividend.
When does Sanjivani Paranteral next pay dividends?
Sanjivani Paranteral does not currently pay a dividend.
How do I buy Sanjivani Paranteral shares?
To buy shares in Sanjivani Paranteral you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sanjivani Paranteral?
As of the previous close price of IN₹240.40, shares in Sanjivani Paranteral had a market capitalisation of IN₹2.83bn.
Where are Sanjivani Paranteral shares listed?
Here are the trading details for Sanjivani Paranteral:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 531569
What kind of share is Sanjivani Paranteral?
Based on an overall assessment of its quality, value and momentum Sanjivani Paranteral is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sanjivani Paranteral share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Sanjivani Paranteral share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sanjivani Paranteral. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -7.4%.
As of the last closing price of IN₹240.40, shares in Sanjivani Paranteral were trading -17.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sanjivani Paranteral PE Ratio?
The Sanjivani Paranteral PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹240.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sanjivani Paranteral?
We do not have data on Sanjivani Paranteral's directors